<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:17:21Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9708555" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9708555</identifier>
        <datestamp>2022-12-01</datestamp>
        <setSpec>npgopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
              <journal-id journal-id-type="iso-abbrev">Mol Psychiatry</journal-id>
              <journal-title-group>
                <journal-title>Molecular Psychiatry</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1359-4184</issn>
              <issn pub-type="epub">1476-5578</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9708555</article-id>
              <article-id pub-id-type="pmcid">PMC9708555</article-id>
              <article-id pub-id-type="pmc-uid">9708555</article-id>
              <article-id pub-id-type="pmid">35546633</article-id>
              <article-id pub-id-type="pmid">35546633</article-id>
              <article-id pub-id-type="publisher-id">1596</article-id>
              <article-id pub-id-type="doi">10.1038/s41380-022-01596-6</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3993-3954</contrib-id>
                  <name>
                    <surname>Rogeau</surname>
                    <given-names>Antoine</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nordio</surname>
                    <given-names>Giovanna</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3562-0683</contrib-id>
                  <name>
                    <surname>Veronese</surname>
                    <given-names>Mattia</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brown</surname>
                    <given-names>Kirsten</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0858-6184</contrib-id>
                  <name>
                    <surname>Nour</surname>
                    <given-names>Matthew M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Osugo</surname>
                    <given-names>Martin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3878-3659</contrib-id>
                  <name>
                    <surname>Jauhar</surname>
                    <given-names>Sameer</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Howes</surname>
                    <given-names>Oliver D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1102-2566</contrib-id>
                  <name>
                    <surname>McCutcheon</surname>
                    <given-names>Robert A.</given-names>
                  </name>
                  <address>
                    <email>robert.mccutcheon@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Department of Neuroimaging, Institute of Psychiatry, Psychology &amp; Neuroscience, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.503422.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2242 6780</institution-id><institution>Department of Nuclear Medicine, </institution><institution>Lille University Hospitals, </institution></institution-wrap>Lille, France </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.5608.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3470</institution-id><institution>Department of Information Engineering, </institution><institution>University of Padua, </institution></institution-wrap>Padua, Italy </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Max Planck UCL Centre for Computational Psychiatry and Ageing Research, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution>Institute of Clinical Sciences, Faculty of Medicine, </institution><institution>Imperial College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution>Psychiatric Imaging Group, MRC London Institute of Medical Sciences, Hammersmith Hospital, </institution><institution>Imperial College London, </institution></institution-wrap>London, UK </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>11</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>11</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2022</year>
              </pub-date>
              <volume>27</volume>
              <issue>8</issue>
              <fpage>3493</fpage>
              <lpage>3500</lpage>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>14</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>21</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">Prefrontal cortex has been shown to regulate striatal dopaminergic function via glutamatergic mechanisms in preclinical studies. Concurrent disruption of these systems is also often seen in neuropsychiatric disease. The simultaneous measurement of striatal dopamine signaling, cortical gray matter, and glutamate levels is therefore of major interest, but has not been previously reported. In the current study, twenty-eight healthy subjects underwent 2 simultaneous [<sup>11</sup>C]-( + )-PHNO PET-MRI scans, once after placebo and once after amphetamine in a double-blind randomized cross-over design, to measure striatal dopamine release, striatal dopamine receptor (D<sub>2/3</sub>R) availability, anterior cingulate glutamate+glutamine (Glx) levels, and cortical gray matter volumes at the same time. Voxel-based morphometry was used to investigate associations between neurochemical measures and gray matter volumes. Whole striatum D<sub>2/3</sub>R availability was positively associated with prefrontal cortex gray matter volume (pFWE corrected = 0.048). This relationship was mainly driven by associative receptor availability (pFWE corrected = 0.023). In addition, an interaction effect was observed between sensorimotor striatum D<sub>2/3</sub>R availability and anterior cingulate Glx, such that in individuals with greater anterior cingulate Glx concentrations, D<sub>2/3</sub>R availability was negatively associated with right frontal cortex gray matter volumes, while a positive D<sub>2/3</sub>R-gray matter association was observed in individuals with lower anterior cingulate Glx levels (pFWE corrected = 0.047). These results are consistent with the hypothesis that the prefrontal cortex is involved in regulation of striatal dopamine function. Furthermore, the observed associations raise the possibility that this regulation may be modulated by anterior cingulate glutamate concentrations.</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Neuroscience</kwd>
                <kwd>Schizophrenia</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000272</institution-id>
                      <institution>DH | National Institute for Health Research (NIHR)</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100004440</institution-id>
                      <institution>Wellcome Trust (Wellcome)</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>215747/Z/19/Z</award-id>
                  <award-id>102186/B/13/Z</award-id>
                  <award-id>094849/Z/10/Z</award-id>
                  <award-id>200102/Z/15/Z</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Veronese</surname>
                      <given-names>Mattia</given-names>
                    </name>
                    <name>
                      <surname>Nour</surname>
                      <given-names>Matthew M.</given-names>
                    </name>
                    <name>
                      <surname>Howes</surname>
                      <given-names>Oliver D.</given-names>
                    </name>
                    <name>
                      <surname>McCutcheon</surname>
                      <given-names>Robert A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000265</institution-id>
                      <institution>RCUK | Medical Research Council (MRC)</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>MC_U120097115</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Howes</surname>
                      <given-names>Oliver D.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100012176</institution-id>
                      <institution>Maudsley Charity</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>666</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Howes</surname>
                      <given-names>Oliver D.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par2">An improved understanding of the relationship between cortical structure and neurochemistry has the potential to advance our pathophysiological understanding of diseases in which simultaneous disruptions exist [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
              <p id="Par3">The striatum exhibits a high degree of connectivity to both the cortex and other subcortical structures [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], and a variety of inputs may regulate striatal dopamine release. There is in vivo evidence that local striatal glutamate concentrations positively correlate with dopamine levels and may precede dopamine release [<xref ref-type="bibr" rid="CR4">4</xref>], but cortical glutamatergic projections to the midbrain also play a role [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Preclinical work suggests this latter circuit involves cortical parvalbumin interneurons, and their activation reduces striatal dopamine release, likely by inhibiting excitatory projections to the midbrain [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
              <p id="Par4">Previous studies in humans have used multimodal neuroimaging to investigate these circuits. Links have been highlighted between frontal gray matter volumes and dopamine, specifically an inverse relationship with dopamine synthesis capacity in people with psychosis [<xref ref-type="bibr" rid="CR8">8</xref>], an inverse relationship with dopamine release and a direct one with D<sub>2</sub> receptor availability in healthy subjects [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. However, these have been examined separately and the interaction with the glutamatergic system has not been previously investigated.</p>
              <p id="Par5">This interaction deserves exploration given the anatomical links between cortex and striatum [<xref ref-type="bibr" rid="CR11">11</xref>], the inverse relationship between cortical glutamate and striatal dopamine synthesis [<xref ref-type="bibr" rid="CR12">12</xref>], and their possible combined involvement through corticostriatal pathways in neuropsychiatric disorders such as schizophrenia [<xref ref-type="bibr" rid="CR5">5</xref>], addiction [<xref ref-type="bibr" rid="CR13">13</xref>], or depression [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
              <p id="Par6">We have previously observed that, in individuals with schizophrenia, lower dorsolateral prefrontal cortex (DLPFC) gray matter volumes are associated with increased striatal dopamine synthesis capacity [<xref ref-type="bibr" rid="CR8">8</xref>]. This is consistent with a model whereby lower gray matter volume reflects fewer synaptic inputs onto cortico-nigral projections, leading to a disinhibition of nigrostriatal dopamine projections and greater striatal dopamine release [<xref ref-type="bibr" rid="CR15">15</xref>]. In line with the view that neurobiological alterations in schizophrenia are a matter of degree rather than categorical [<xref ref-type="bibr" rid="CR16">16</xref>], we hypothesized a similar relationship in healthy individuals, albeit the absolute values are different from those in people with schizophrenia. The binding of D<sub>2/3</sub> receptor ligands is sensitive to the synaptic levels of dopamine [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. With a D<sub>2/3</sub> receptor ligand one would therefore expect to see lower DLPFC gray matter volumes associated with lower binding in the striatum, as lower ligand binding can be taken to represent greater synaptic dopamine levels. Of note, in the previous study, the association between DLPFC gray matter volume and striatal dopamine function was not observed in patients who had not responded to treatment, and treatment response has been associated with lower magnetic resonance spectroscopy (MRS) measured glutamate levels compared to treatment non-responsive schizophrenia [<xref ref-type="bibr" rid="CR19">19</xref>]. We therefore also hypothesized that a similar interaction might exist in healthy individuals whereby individuals with lower glutamate levels would show this directionality, in contrast to those with higher levels.</p>
              <p id="Par7">Dopaminergic function can be assessed in vivo using positron emission tomography (PET). The ligand [<sup>11</sup>C]-( + )-PHNO is able to index striatal D<sub>2/3</sub> receptor availability, and, in conjunction with amphetamine administration, can measure dopamine release [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. The combined glutamatergic metabolites, glutamate+glutamine (Glx) can be measured using proton MRS [<xref ref-type="bibr" rid="CR19">19</xref>], while T1 structural magnetic resonance imaging (MRI) allows for quantification of gray matter volume [<xref ref-type="bibr" rid="CR21">21</xref>]. The use of simultaneous PET-MRI offers the advantages of eliminating potential chronological confounds, reduced within-subject variability, and improved spatial resolution [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].</p>
              <p id="Par8">In the present study, we set out to investigate relationships between prefrontal cortex (PFC) gray matter volumes, anterior cingulate cortex (ACC) Glx levels, striatal dopamine receptors, and striatal dopamine release using a simultaneous [<sup>11</sup>C]-( + )-PHNO PET-MRI in a sample of healthy participants. Specifically, we hypothesized to find a direct relationship between PFC gray matter volumes and striatal dopamine receptor availability, an inverse relationship between PFC gray matter volumes and amphetamine-induced dopamine release, and these relationships to be modulated by ACC Glx concentrations.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <p id="Par9">The study was approved by the local National Health Service (NHS) Research Ethics Committee (12/LO/1955) and the Administration of Radioactive Substances Advisory Committee. PET data were previously reported in McCutcheon et al. [<xref ref-type="bibr" rid="CR24">24</xref>], but the relationship with structural MRI and [<sup>1</sup>H]-MRS measures have not been previously reported.</p>
              <sec id="Sec3">
                <title>Participants</title>
                <p id="Par10">Twenty-eight participants were enrolled through online advertising. Inclusion criteria were age 18 or above and ability to give informed consent. Exclusion criteria included contraindications to MRI or PET scanning (pregnancy, breastfeeding, significant prior exposure to ionizing radiation) or amphetamine administration (hypersensitivity, concurrent monoamine oxidase inhibitor therapy, cardiovascular disease, hyperthyroidism), current or previous significant medical co-morbidity, past traumatic brain injury with loss of consciousness, background of neurological condition or psychiatric disorder (including substance use disorder) as determined by medical review and the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV), and history of psychiatric disorder in first-degree relatives. Information concerning tobacco and cannabis use was collected. Subjects smoking at least one cigarette daily were considered smokers, five subjects had consumed cannabis at least once and only one subject regularly used on a weekly basis. All subjects provided informed written consent.</p>
              </sec>
              <sec id="Sec4">
                <title>Scanning procedure</title>
                <p id="Par11">Participants were asked to attend two imaging sessions separated by a minimum of 3 days, during which simultaneous PET-MRI scans were acquired. One session was performed under placebo condition (101 mg of lactose/sucrose tablets), the other after oral dexamphetamine administration (0.5 mg/kg). Scanning was initiated 3 h after placebo or amphetamine administration [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Placebo/amphetamine order was determined by prior randomization. Participants and staff involved in the scan sessions were blind to the condition, the number of administered placebo tablets were matched to the number of amphetamine tablets, and blinding was maintained throughout the scanning sessions. Researchers were also blind to drug status during initial image analysis.</p>
                <p id="Par12">PET-MRI data were acquired simultaneously using a General Electric (Milwaukee, WI, USA) SIGNA 3 Tesla scanner. Dynamic PET data were acquired over 90 min using 26 frames (8 × 15 s, 3 × 60 s, 5 × 120 s, 5 × 300 s, 5 × 600 s), immediately following the administration of a bolus of [<sup>11</sup>C]-( + )-PHNO over 30 s (dose 0.020–0.029 μg/kg; mean mass 1.44 μg, mean injected activity 140 MBq), PHNO is a dopaminergic agonist binding D<sub>3</sub> receptors and high affinity D<sub>2</sub> receptors [<xref ref-type="bibr" rid="CR26">26</xref>]. [<sup>11</sup>C]-( + )-PHNO PET has an excellent reproducibility with intraclass correlation &gt;0.9 for the striatum/pallidum [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], while radiotracer specific binding is sensitive to endogenous dopamine release following amphetamine administration [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
                <p id="Par13">PET signal at the beginning of the acquisition rapidly changes and is essential for modeling. Heat generated by the MRI gradient coils was noted to slightly affect the PET signal, so to preserve the integrity of the signal MRI scanning was started 10 min after the initiation of PET scanning [<xref ref-type="bibr" rid="CR29">29</xref>]. Following the initial 10 min period of PET-only scanning, the acquisition continued with simultaneous PET-MRI scanning. An attenuation correction map was generated through zero echo time (ZTE)–based MR with the following settings: flip angle = 0.8°, voxel size = 2.4 mm isotropic, matrix = 110 × 110 × 116, acquisition time = 42 s, number of averages = 4, and bandwidth = ± 62.5 kHz. Reconstruction of dynamic PET images was performed with the Vue Point FX-S (VPFX-S) algorithm based on a 3D Ordered Subset Expectation Maximization (OSEM) algorithm that also includes point spread function modeling and time-of-flight information [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. It corrected for detector normalization, randoms, scatter, dead time, and radioactive decay with the following parameters: 6 iterations, 16 subsets, no post-reconstruction smoothing, voxel size = 2 × 2 x 2.78 mm, and matrix = 128 × 128 × 89. Finally, the previously generated ZTE map was used for attenuation correction [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
                <p id="Par14">A 3-dimensional BRAVO T1-weighted structural scan was acquired using the following settings: inversion time (TI) = 400 ms, TE = 3.2 ms, repetition time (TR) = 8.5 ms, flip angle = 12°, 1 mm isotropic voxels, matrix = 256 × 256, and number of slices = 188. To acquire [<sup>1</sup>H]-MRS data, a 20 × 20 x 20 mm voxel was placed midline on the anterior cingulate (ACC) region (Supplementary Fig. <xref rid="MOESM6" ref-type="media">S1</xref>), 13 mm above the anterior portion of the corpus callosum genu and perpendicular to the anterior commissure–posterior commissure line to maximize gray matter inclusion [<xref ref-type="bibr" rid="CR33">33</xref>]. Auto prescans were used for shimming and water suppression enhancement. Point RESolved Spectroscopy (PRESS) spectra were obtained via the General Electric PROton Brain Examination (PROBE) sequence including water suppression with the following parameters: TE = 30 ms, TR = 3 s, and 96 averages.</p>
              </sec>
              <sec id="Sec5">
                <title>Image analysis</title>
                <sec id="Sec6">
                  <title>Positron emission tomography</title>
                  <p id="Par15">The Molecular Imaging And Kinetic Analysis Toolbox (MIAKAT) version 4.3.13 in MATLAB 8.2 (MathWorks, Natick, MA, USA) was used for PET data analysis [<xref ref-type="bibr" rid="CR34">34</xref>]. The motion was corrected by registering each frame of the dynamic sequence on a single frame of reference, which was the sixteenth frame acquired between 13–15 min after injection [<xref ref-type="bibr" rid="CR35">35</xref>]. Each subject’s PET scan was then coregistered to their T1 structural scan.</p>
                  <p id="Par16">The Montreal Neurological Institute (MNI) structural template underwent a non-linear transformation to allow co-registration to each subject’s T1 structural scan. An in-house MNI-based atlas including the whole striatum, its limbic, associative, and sensorimotor functional subdivisions (as defined by Martinez et al. [<xref ref-type="bibr" rid="CR36">36</xref>]) underwent the same transformation. Then, using a simplified reference tissue model (SRTM) and the voxel time activity curves, the nondisplaceable binding potential (BP<sub>ND</sub>) of [<sup>11</sup>C]-( + )-PHNO was estimated at each voxel [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. The cerebellum was chosen as the reference region due to its low D<sub>2/3</sub> receptor binding [<xref ref-type="bibr" rid="CR39">39</xref>], and each participant’s mean BP<sub>ND</sub> were calculated for each region-of-interest (ROI). D<sub>2/3</sub> receptor availability at baseline is given by BP<sub>ND</sub> under placebo condition. Dopamine release (∆BP<sub>ND</sub>) can be estimated by quantifying the change between placebo and amphetamine conditions in proportion to baseline as follows:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta BPND = 100 \times \frac{{BPND_{placebo} - BPND_{amphetamine}}}{{BPND_{placebo}}}\%$$\end{document}</tex-math><mml:math id="M2"><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>N</mml:mi><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>N</mml:mi><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>N</mml:mi><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mi>%</mml:mi></mml:math><graphic xlink:href="41380_2022_1596_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
                  <p id="Par17">Whole striatal dopamine receptor availability and amphetamine-induced dopamine release were used for the primary analysis, while additional exploratory analyses were conducted for the striatal functional subdivisions.</p>
                </sec>
                <sec id="Sec7">
                  <title>MRS analysis</title>
                  <p id="Par18">Glutamate + glutamine (Glx) levels were assessed with an LCModel 6.3-I0 (<ext-link ext-link-type="uri" xlink:href="http://s-provencher.com/lcmodel.shtml">http://s-provencher.com/lcmodel.shtml</ext-link>). Quality of spectra was inspected and metabolites demonstrating a line width (full width at half maximum) ≤0.1 ppm, Cramér–Rao lower bounds ≤20%, and signal to noise ratio ≥5 were analyzed. The Statistical Parametric Mapping 12 (SPM12; Wellcome Trust Centre for Neuroimaging, London, UK, <ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm">http://www.fil.ion.ucl.ac.uk/spm</ext-link>) segmentation algorithm was used to identify relative distribution of white, gray matter, and CSF in the ACC voxel. CSF inclusion was corrected for with the following formula where M<sub>corr</sub> = corrected metabolite value, M = raw metabolite value, WM = white matter, and GM = gray matter:<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_{corr} = \frac{{M \times \left( {\left[ {WM + GM} \right] \times 1.22 + \left[ {CSF \times 1.55} \right]} \right)}}{{WM + GM}}$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>M</mml:mi><mml:mo>×</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi>W</mml:mi><mml:mi>M</mml:mi><mml:mo>+</mml:mo><mml:mi>G</mml:mi><mml:mi>M</mml:mi></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mn>1.22</mml:mn><mml:mo>+</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mi>C</mml:mi><mml:mi>S</mml:mi><mml:mi>F</mml:mi><mml:mo>×</mml:mo><mml:mn>1.55</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>W</mml:mi><mml:mi>M</mml:mi><mml:mo>+</mml:mo><mml:mi>G</mml:mi><mml:mi>M</mml:mi></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41380_2022_1596_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
                </sec>
              </sec>
              <sec id="Sec8">
                <title>Voxel-based morphometry</title>
                <p id="Par19">Voxel-Based Morphometry (VBM) analysis was performed using SPM12 in MATLAB 8.2. This analysis examined relationships between gray matter volumes and (1) D<sub>2/3</sub> receptor availability (BP<sub>NDplacebo</sub>), (2) amphetamine-induced dopamine release (∆BP<sub>ND</sub>), (3) ACC Glx concentrations, and (4) the interaction between dopamine and glutamate measures. MR data acquired during the placebo sessions were used for all analyses. All T1 structural scans were checked for artefacts, gross abnormalities or poor quality, and the origin was set to the anterior commissure. Images were segmented into gray, white matter and cerebrospinal fluid using the SPM12 probability maps. The Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DARTEL) pipeline was used to improve intersubject registration, especially of small structures [<xref ref-type="bibr" rid="CR40">40</xref>], and generated gray matter images were subsequently normalized to MNI space, modulated, resliced (1.5 mm isotropic voxels) and smoothed with a 10 mm full width at half maximum (FWHM). Intracranial volumes (ICV) were calculated in the “Tissue Volume” tab [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
                <p id="Par20">A separate multiple regression model including the intercept and total ICV as nuisance regressors was fitted for each of the three predictor variables of interest: D<sub>2/3</sub> receptor availability, dopamine release, and ACC Glx. We fitted two additional general linear models for the interaction analysis. Here, the intercept, total ICV, BP<sub>NDplacebo</sub> or ΔBP<sub>ND</sub> and Glx were included as nuisance regressors, and mean-centering was performed to orthogonalize the interaction term against main effects. Additional general linear models including age, tobacco smoking and cannabis use as covariates were computed. Dopamine receptor availability, amphetamine-induced release and ACC Glx analyses were preregistered while interaction analyses were conducted post hoc (<xref rid="MOESM1" ref-type="media">supplementary information</xref>).</p>
                <p id="Par21">A mask comprising Brodmann Area 9 and 46 was generated from the Wake Forest University (WFU) PickAtlas to constrain the analysis to the prefrontal cortex [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. This region was a priori selected based on our earlier finding of an interaction between its gray matter volume, striatal dopamine synthesis and treatment response in schizophrenia [<xref ref-type="bibr" rid="CR8">8</xref>], and the consistent anatomical and functional links between prefrontal cortex and striatum in health and disease [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. We used a 1-point dilation to generate the mask since without it did not include the entire cortical thickness (Supplementary Fig. <xref rid="MOESM7" ref-type="media">S2</xref>). Peak-level family-wise error correction (pFWE &lt; 0.05) within this ROI was used to assess significance of the results. Gray matter volume data of peak voxels showing correlation with regressors were extracted using the MarsBar 0.44 toolbox (<ext-link ext-link-type="uri" xlink:href="http://marsbar.sourceforge.net">http://marsbar.sourceforge.net</ext-link>) in SPM12. We used the GraphPad Prism 9 software (<ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link>) to draw scatter plots. The MRIcroGL software (<ext-link ext-link-type="uri" xlink:href="https://www.nitrc.org/projects/mricrogl">https://www.nitrc.org/projects/mricrogl</ext-link>) was used for visualization of results and brain rendering [<xref ref-type="bibr" rid="CR46">46</xref>]. Exploratory analyses on the whole brain, using glutamate (Glu) and linear regressions between other variables were thereafter performed and can be found in the <xref rid="MOESM1" ref-type="media">Supplementary Information</xref> (Supplementary Tables <xref rid="MOESM2" ref-type="media">S1</xref>–<xref rid="MOESM4" ref-type="media">3</xref>).</p>
              </sec>
            </sec>
            <sec id="Sec9" sec-type="results">
              <title>Results</title>
              <sec id="Sec10">
                <title>Subject details</title>
                <p id="Par22">Subject demographics, PET and MRS results are summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. Twenty-five subjects attended both sessions, 2 subjects attended the placebo session only, and 1 subject attended the amphetamine session only. The subject that attended only the amphetamine session was excluded, and a subject for whom PET images were unusable was excluded from all analyses involving PET data (Supplementary Fig. <xref rid="MOESM8" ref-type="media">S3</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Subject demographics, PET and MRS results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Subjects (<italic>N</italic> = 28)</th><th colspan="6">Mean (SD) or %</th></tr></thead><tbody><tr><td>Age (years)</td><td colspan="6">23.8 (4.7)</td></tr><tr><td>Female</td><td colspan="6">59.30%</td></tr><tr><td>Tobacco</td><td colspan="6">10.70%</td></tr><tr><td>Cannabis</td><td colspan="6">17.90%</td></tr><tr><td><bold>Ethnicity</bold></td><td><bold>Black African</bold></td><td><bold>Chinese</bold></td><td colspan="2"><bold>Indian</bold></td><td><bold>White</bold></td><td><bold>Other</bold></td></tr><tr><td/><td>11.10%</td><td>11.10%</td><td colspan="2">22.20%</td><td>37.10%</td><td>18.50%</td></tr><tr><td>Right-handed</td><td colspan="6">88.90%</td></tr><tr><td/><td colspan="3"><bold>Placebo [mean (SD)]</bold></td><td colspan="3"><bold>Amphetamine [mean (SD)]</bold></td></tr><tr><td>BP<sub>ND</sub> whole striatum</td><td colspan="3">2.52 (0.29)</td><td colspan="3">2.01 (0.29)</td></tr><tr><td>BP<sub>ND</sub> sensorimotor striatum</td><td colspan="3">2.59 (0.32)</td><td colspan="3">1.9 (0.28)</td></tr><tr><td>BP<sub>ND</sub> associative striatum</td><td colspan="3">2.43 (0.29)</td><td colspan="3">2.06 (0.31)</td></tr><tr><td>BP<sub>ND</sub> limbic striatum</td><td colspan="3">2.95 (0.54)</td><td colspan="3">2.28 (0.42)</td></tr><tr><td>Glx in anterior cingulate cortex</td><td colspan="3">20.84 (3.89)</td><td colspan="3">21.79 (3.5)</td></tr><tr><td>GM proportion in ACC voxel</td><td colspan="3">62.3% (15%)</td><td colspan="3">63.6% (7.2%)</td></tr><tr><td>WM proportion in ACC voxel</td><td colspan="3">15.6% (19.6%)</td><td colspan="3">12.2% (6%)</td></tr><tr><td>CSF proportion in ACC voxel</td><td colspan="3">22% (9.8%)</td><td colspan="3">23.3% (8.5%)</td></tr></tbody></table><table-wrap-foot><p><italic>ACC</italic> Anterior cingulate cortex, <italic>BP</italic><sub><italic>ND</italic></sub> Nondisplaceable binding potential, <italic>CSF</italic> Cerebrospinal fluid, <italic>Glx</italic> Glutamate+glutamine, <italic>GM</italic> Gray matter, <italic>SD</italic> Standard deviation, <italic>WM</italic> White matter.</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec11">
                <title>Relationship between dopamine 2/3 receptor availability and gray matter volume</title>
                <p id="Par23">We found a region (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) in the right DLPFC that positively correlated with D<sub>2/3</sub> receptor availability in the whole striatum (BA9: x = 45, y = 10, z = 33; k = 143, pFWE corrected = 0.048). When repeating the same procedure for the striatal subdivisions (Supplementary Fig. <xref rid="MOESM9" ref-type="media">S4</xref>), the same region correlated with associative (pFWE = 0.028), but not with sensorimotor or limbic subdivisions. When including age, tobacco and cannabis as covariates, the same association was strengthened with the whole striatal (pFWE = 0.007) and the associative (pFWE = 0.005) D<sub>2/3</sub> receptor availabilities, and was also observed for the limbic region (pFWE = 0.042).<fig id="Fig1"><label>Fig. 1</label><caption><title>Positive correlation between gray matter volume of a right prefrontal cluster and dopamine receptor availability at baseline in whole striatum.</title><p><bold>A</bold> Voxels significant at <italic>p</italic> &lt; 0.05 (FWE corrected) shown, color bar represents T-score. <bold>B</bold> Scatter plot of gray matter density from the significant cluster against whole striatum BP<sub>NDplacebo</sub>.</p></caption><graphic xlink:href="41380_2022_1596_Fig1_HTML" id="d32e1221"/></fig></p>
              </sec>
              <sec id="Sec12">
                <title>Relationship between amphetamine-induced dopamine release and gray matter volume</title>
                <p id="Par24">Binding was significantly lower after amphetamine administration in all ROIs (Supplementary Fig. <xref rid="MOESM10" ref-type="media">S5</xref>, all <italic>p</italic>-values &lt; 0.0005), reflecting displacement of the radiotracer by endogenous dopamine [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Mean whole striatal reduction in ligand binding was 20.4%, standard deviation (SD) = 9.4%. We did not find any regions in the prefrontal cortex that were significantly associated with striatal dopamine release using ΔBP<sub>ND</sub> as regressor. There was no correlation either when adding age, tobacco and cannabis as covariates. However, in the exploratory analysis, there was a significant inverse relationship between gray matter volume in an orbitofrontal region (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) and sensorimotor ΔBP<sub>ND</sub> (BA47: x = −40, y = 40, z = −14; k = 1462, pFWE corrected = 0.043). This significant relationship was not found when examining whole striatal ΔBP<sub>ND</sub> (pFWE = 0.16).<fig id="Fig2"><label>Fig. 2</label><caption><title>Negative correlation between gray matter volume of a left orbitofrontal cluster and amphetamine-induced dopamine release in sensorimotor striatum.</title><p><bold>A</bold> Voxels significant at <italic>p</italic> &lt; 0.05 (FWE corrected) shown, color bar represents T-score. <bold>B</bold> Scatter plot of gray matter density from the significant cluster against sensorimotor striatum ΔBP<sub>ND</sub>.</p></caption><graphic xlink:href="41380_2022_1596_Fig2_HTML" id="d32e1273"/></fig></p>
              </sec>
              <sec id="Sec13">
                <title>Relationship between anterior cingulate cortex Glx and gray matter volume</title>
                <p id="Par25">Spectroscopic spectra showed mean fit Cramér-Rao lower bounds = 7.1%, SD = 1.7% and range = 5–12%. Mean FWHM was 0.06 ppm, SD = 0.03, and mean signal-to-noise ratio was 12.7 and SD = 3.3. We found a cluster in the left prefrontal cortex that showed a positive association with ACC Glx levels, although only at trend significance (BA46: x = −51, y = 27, z = 22; k = 72, pFWE corrected = 0.065). This trend persisted when using age, tobacco and cannabis as covariates (pFWE = 0.071). We did not find any other prefrontal regions that showed significant association with ACC Glx levels.</p>
              </sec>
              <sec id="Sec14">
                <title>Dopamine receptor and release x Glx interactions</title>
                <p id="Par26">A cluster in the right frontal cortex (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) showed a significant negative correlation with the interaction term sensorimotor BP<sub>NDplacebo</sub>:Glx (BA6: x = 54, y = −3, z = 22; k = 39, pFWE corrected = 0.047) but not with the whole striatum or other subdivisions. This same correlation persisted using the model including age, tobacco and cannabis as covariates (pFWE = 0.049). For illustration purposes, we used a median split to separate subjects into low vs. high Glx levels, demonstrating that individuals with greater Glx concentrations showed dopamine D<sub>2/3</sub> receptor availability that was negatively associated with right frontal cortex gray matter volumes, while a positive Glx-gray matter volume association was observed in individuals with lower Glx levels (Fig. <xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Gray matter volume showing a negative correlation with the interaction term sensorimotor BPNDplacebo:Glx.</title><p><bold>A</bold> Voxels significant at <italic>p</italic> <italic>&lt;</italic> 0.05 (FWE corrected) shown, color bar represents T-score. <bold>B</bold> Median splitting was performed to graphically separate subjects with low or high Glx levels. Subjects with low Glx levels show increase in gray matter volume at voxel [54, −3, 22] along increase in sensorimotor receptor availability while subjects with high Glx levels demonstrate the inverse relationship.</p></caption><graphic xlink:href="41380_2022_1596_Fig3_HTML" id="d32e1317"/></fig></p>
                <p id="Par27">No other gray matter regions showed significant association with the interaction term BP<sub>NDplacebo</sub>:Glx. When testing for the ΔBP<sub>ND</sub>:Glx interaction using the basic or the covariate models, no gray matter clusters showed a significant association.</p>
              </sec>
            </sec>
            <sec id="Sec15" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par28">Our primary findings are that striatal dopamine receptor availability is positively associated with gray matter volumes in the right DLPFC, and evidence for an interaction effect on right frontal cortical gray matter volume between sensorimotor dopamine receptors and ACC Glx levels.</p>
              <p id="Par29">The fact that gray matter volumes most strongly correlated with associative striatum dopamine receptor availability is consistent with the fact that corticostriatal tracts originating from the DLPFC primarily make contact with it [<xref ref-type="bibr" rid="CR11">11</xref>]. Our findings are in agreement with previous work showing a positive correlation between associative striatum dopamine receptor availability and DLPFC gray matter volume [<xref ref-type="bibr" rid="CR10">10</xref>]. Interestingly, the cluster identified in the earlier study was in the left DLPFC contrary to the right side in the present study. This inconsistency might be linked to small sample sizes for both studies and bilateral DLPFC volume may be linked to striatal receptors. Supporting this interpretation, a non-significant positive left sided association was observed in the current sample (Supplementary Fig. <xref rid="MOESM11" ref-type="media">S6</xref>). The main difference in the previous study is the use of [<sup>11</sup>C]-raclopride compared to [<sup>11</sup>C]-( + )-PHNO in the current study. PHNO binds D<sub>3</sub> receptors in addition to high affinity D<sub>2</sub> receptors, whereas raclopride binds to both high and low affinity state receptors [<xref ref-type="bibr" rid="CR48">48</xref>]. The current findings, therefore, suggest that while D<sub>2/3</sub> high affinity receptors are associated with prefrontal cortex gray matter concentrations, it is unclear if other dopamine receptor subtypes show a similar relationship. There is evidence that PFC projections act to limit striatal dopamine signaling, and if receptor availability is assumed to negatively correlate with synaptic dopamine levels the current findings are consistent with a model in which individuals with lower DLPFC gray matter volumes have reduced inhibition of striatal dopamine signaling. Consistent with this interpretation, lower orbitofrontal gray matter volumes were also associated with greater amphetamine-induced dopamine release in the sensorimotor striatum.</p>
              <p id="Par30">We also found a significant interaction effect between sensorimotor dopamine receptor availability and ACC Glx levels. We therefore show an opposite relationship between dopamine receptor availability and gray matter volume depending on whether subjects have low or high ACC glutamate concentrations (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). This finding is of interest given our previous finding of an association between dopamine function and gray matter volumes in individuals with psychosis modulated by treatment response [<xref ref-type="bibr" rid="CR8">8</xref>]. These two results are potentially consistent, given the evidence that treatment response may relate to glutamate concentrations, in that individuals who respond to antipsychotic have lower ACC Glx concentrations compared to those who do not [<xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR51">51</xref>]. This raises the possibility that the interaction effect observed in the analysis of D’Ambrosio et al. relating to treatment response may reflect the glutamate levels of those patients, in line with the results of the current study. Finally, the region where we localized the interaction effect includes the premotor cortex which is directly connected to the sensorimotor striatum. Likewise, the ACC also presents connections with the premotor cortex, and there are direct striatum-ACC links [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], illustrating potential anatomical pathways via which this relationship may be mediated.</p>
              <p id="Par31">Although we found a left orbitofrontal volume showing an inverse relationship with amphetamine-induced dopamine release in the sensorimotor striatum, we did not find any significant association for PFC gray matter volumes. In this context, it follows that we did not find any significant interaction between dopamine release and ACC glutamate. We thus failed to replicate a previous finding of an inverse relationship between prefrontal thickness and striatal dopamine release [<xref ref-type="bibr" rid="CR9">9</xref>], although the methodology between this study and ours varies greatly. Aside from regulation by cortical projections, local cholinergic interneurons contribute to striatal dopaminergic regulation through nicotinic and muscarinic receptors expressed on striatal dopaminergic neurons [<xref ref-type="bibr" rid="CR53">53</xref>]. Therefore, we speculate that the absence of relationship between dopamine release and prefrontal gray matter volumes suggests the former may be locally regulated by cholinergic interneurons or by other cortical regions while striatal dopamine receptor availability may reflect long-range regulation from the DLPFC.</p>
              <p id="Par32">If confirmed, this could indicate promising avenues for treatment, as it adds to evidence that dysfunction is presynaptic while current treatments primarily target postsynaptic dopamine receptors [<xref ref-type="bibr" rid="CR54">54</xref>]. Trace amine-associated receptor 1 (TAAR1) agonists and M4 positive allosteric modulators, both could reduce mesostriatal dopamine release and have demonstrated positive results in a phase II trial [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>].</p>
              <sec id="Sec16">
                <title>Strengths and limitations</title>
                <p id="Par33">Although the relationship between gray matter volumes and neurochemical systems has been previously studied [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], this multimodal study is to our knowledge the first investigating cortex volume in relation to the different aspects of dopaminergic (amphetamine-induced release and receptor availability) and glutamatergic function in the same group of subjects. The study in the same subjects of different components of the dopaminergic neurotransmission and the interaction with the glutamatergic system allows to show that the significant gray matter regions slightly overlap in the dorsolateral prefrontal region (Figs. <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig3" ref-type="fig">3</xref>). This leads to think that a similar study in a larger sample may show further influence of glutamate on the association between striatal dopamine and PFC gray matter volumes. In addition, the use of voxel-based morphometry in SPM12, a free and widespread software, allows for replicability of these findings and robust comparability with other findings based on the same methods.</p>
                <p id="Par34">While the use of [<sup>11</sup>C]-( + )-PHNO BP<sub>ND</sub> to estimate D<sub>2/3</sub> receptor availability and dopamine release is well validated, our cross-over design could lead to carry-over effects for subjects who received amphetamine first. A 3-day washout period should, however, allow for good elimination of a product with a 10 h half-life [<xref ref-type="bibr" rid="CR59">59</xref>]. Despite blinding in the present study, subjects experienced greater subjective drug effects when receiving amphetamine which may have led to some subjects being effectively unblinded [<xref ref-type="bibr" rid="CR24">24</xref>]. Despite this as analyses were focused on neuroimaging variables rather than subjective report, and volunteers were blind to hypotheses, any inadvertent unblinding is unlikely to have significantly influenced results.</p>
                <p id="Par35">It is not possible with current neuroimaging measures to identify which precise gray matter component underlies the observed relationship between striatal dopamine and gray matter volume. In addition, although participants were screened regarding cannabis use, past substance use may still have been unreported and may have the potential to contribute to the observed findings. While smaller gray matter volumes are often equated to fewer projection neurons, intracortical neuropil, glial cells, interneurons could also contribute to the observed findings. Similarly, [<sup>1</sup>H]-MRS is unable to distinguish between intra- and extra-cellular glutamate limiting the precision of possible inferences [<xref ref-type="bibr" rid="CR60">60</xref>]. Although we show an interaction between glutamate and dopamine on PFC gray matter volumes, this interaction’s mechanisms are not explored with the present design, and a mediation analysis on a larger sample in a future study may help elucidate them. Finally, these results should still be viewed as preliminary given the moderate sample size and the fact that although stringent multiple comparison correction was employed for each individual analysis, multiple analyses were undertaken.</p>
              </sec>
            </sec>
            <sec id="Sec17" sec-type="conclusion">
              <title>Conclusion</title>
              <p id="Par36">In the current study, we demonstrated that the availability of dopamine receptors in the bilateral whole striatum and in the associative subregion positively correlate with right prefrontal gray matter volume, and that there was a negative interactive effect of ACC Glx on a right frontal gray matter volume. These results extend previous findings in schizophrenia and healthy participants to demonstrate interaction across all three systems, with relevance for our understanding of neuropsychiatric disease in which abnormalities are often found to occur simultaneously.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec18">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41380_2022_1596_MOESM1_ESM.doc">
                      <caption>
                        <p>Supplementary information</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="41380_2022_1596_MOESM2_ESM.xls">
                      <caption>
                        <p>Supplementary Table 1</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM3">
                    <media xlink:href="41380_2022_1596_MOESM3_ESM.xls">
                      <caption>
                        <p>Supplementary Table 2</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM4">
                    <media xlink:href="41380_2022_1596_MOESM4_ESM.xls">
                      <caption>
                        <p>Supplementary Table 3</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM5">
                    <media xlink:href="41380_2022_1596_MOESM5_ESM.xls">
                      <caption>
                        <p>Supplementary Table 4</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM6">
                    <media xlink:href="41380_2022_1596_MOESM6_ESM.jpg">
                      <caption>
                        <p>Supplementary Figure 1</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM7">
                    <media xlink:href="41380_2022_1596_MOESM7_ESM.png">
                      <caption>
                        <p>Supplementary Figure 2</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM8">
                    <media xlink:href="41380_2022_1596_MOESM8_ESM.png">
                      <caption>
                        <p>Supplementary Figure 3</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM9">
                    <media xlink:href="41380_2022_1596_MOESM9_ESM.png">
                      <caption>
                        <p>Supplementary Figure 4</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM10">
                    <media xlink:href="41380_2022_1596_MOESM10_ESM.jpg">
                      <caption>
                        <p>Supplementary Figure 5</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM11">
                    <media xlink:href="41380_2022_1596_MOESM11_ESM.jpg">
                      <caption>
                        <p>Supplementary Figure 6</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p>The online version contains supplementary material available at 10.1038/s41380-022-01596-6.</p>
            </sec>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>AR conceived the idea, performed the analysis and wrote the article. GN conceived the idea and wrote the article. MV conceived the idea, preprocessed data and wrote the article. KB obtained data and wrote the article. MMN obtained data and wrote the article. MO obtained data and wrote the article. SJ obtained data and wrote the article. ODH obtained funding and wrote the article. RAM conceived the idea, obtained funding, obtained data, preprocessed data and wrote the article.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>RAM work was supported by the Wellcome Trust Clinical Research Training Fellowship (grant no. 200102/Z/15/Z) and a National Institute for Health Research (NIHR) academic clinical lectureship. MMN is supported by a University College London (UCL) Welcome PhD Fellowship for Clinicians (102186/B/13/Z) and is a predoctoral fellow of the International Max Planck Research School on Computational Methods in Psychiatry and Ageing Research (IMPRS COMP2PSYCH, <ext-link ext-link-type="uri" xlink:href="https://www.mps-ucl-centre.mpg.de/comp2psych">https://www.mps-ucl-centre.mpg.de/comp2psych</ext-link>). SJ work is funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. ODH work is funded by the Medical Research Council-UK (no. MC_U120097115), Maudsley Charity (no. 666), and Wellcome Trust (no. 094849/Z/10/Z) grants and the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. MV work is funded by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King’s College London, and by the Wellcome Trust Digital Award 215747/Z/19/Z. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Code availability</title>
              <p>Neuroimaging data and analysis scripts are publicly available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/rogeauA/PFC_GrayMatter_DA-Glx">https://github.com/rogeauA/PFC_GrayMatter_DA-Glx</ext-link>).</p>
            </notes>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par37">RAM has received honoraria for educational talks from Otsuka and Janssen. ODH has received investigator-initiated research funding from and/or participated in advisory/ speaker meetings organized by Angellini, Astra-Zeneca, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Invicro, Janssen, Lundbeck, Lyden-Delta, Mylan, Neurocrine, Otsuka, Sunovion, Rand, Recordati, and Roche. Neither ODH or his family have been employed by or have holdings/ a financial stake in any pharmaceutical company. MV has received consulting honoraria from GSK. ODH and MV hold a patent application for the use of dopamine imaging as a prognostic tool. SJ has received honoraria for educational talks from Sunovian and his employer (King’s College London) has received honoraria.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaminski</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Mascarell-Maricic</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Fukuda</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Katthagen</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Heinz</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Schlagenhauf</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Glutamate in the dorsolateral prefrontal cortex in patients with schizophrenia: a meta-analysis of (1)H-magnetic resonance spectroscopy studies</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2021</year>
                  <volume>89</volume>
                  <fpage>270</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biopsych.2020.09.001</pub-id>
                  <?supplied-pmid 33129486?>
                  <pub-id pub-id-type="pmid">33129486</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Calabresi</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Picconi</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Tozzi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ghiglieri</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Di</surname>
                    </name>
                    <name>
                      <surname>Filippo</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Direct and indirect pathways of basal ganglia: a critical reappraisal</article-title>
                  <source>Nat Neurosci</source>
                  <year>2014</year>
                  <volume>17</volume>
                  <fpage>1022</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="doi">10.1038/nn.3743</pub-id>
                  <?supplied-pmid 25065439?>
                  <pub-id pub-id-type="pmid">25065439</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Peters</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Dunlop</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Downar</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Cortico-striatal-thalamic loop circuits of the salience network: a central pathway in psychiatric disease and treatment</article-title>
                  <source>Front Syst Neurosci</source>
                  <year>2016</year>
                  <volume>10</volume>
                  <fpage>104</fpage>
                  <pub-id pub-id-type="doi">10.3389/fnsys.2016.00104</pub-id>
                  <?supplied-pmid 28082874?>
                  <pub-id pub-id-type="pmid">28082874</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lorenz</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Gleich</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Buchert</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Schlagenhauf</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Kuhn</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gallinat</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum</article-title>
                  <source>Hum Brain Mapp</source>
                  <year>2015</year>
                  <volume>36</volume>
                  <fpage>4031</fpage>
                  <lpage>40</lpage>
                  <pub-id pub-id-type="doi">10.1002/hbm.22895</pub-id>
                  <?supplied-pmid 26177932?>
                  <pub-id pub-id-type="pmid">26177932</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schwartz</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Sachdeva</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Stahl</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Glutamate neurocircuitry: theoretical underpinnings in schizophrenia</article-title>
                  <source>Front Pharm</source>
                  <year>2012</year>
                  <volume>3</volume>
                  <fpage>195</fpage>
                  <pub-id pub-id-type="doi">10.3389/fphar.2012.00195</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Karreman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Moghaddam</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area</article-title>
                  <source>J Neurochem</source>
                  <year>1996</year>
                  <volume>66</volume>
                  <fpage>589</fpage>
                  <lpage>98</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.66020589.x</pub-id>
                  <?supplied-pmid 8592128?>
                  <pub-id pub-id-type="pmid">8592128</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kokkinou</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Irvine</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Bonsall</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Natesan</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Wells</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Simth</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine</article-title>
                  <source>Mol Psychiatry.</source>
                  <year>2021</year>
                  <volume>26</volume>
                  <fpage>2562</fpage>
                  <lpage>76</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41380-020-0740-6</pub-id>
                  <?supplied-pmid 32382134?>
                  <pub-id pub-id-type="pmid">32382134</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>D’Ambrosio</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Jauhar</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Veronese</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Rogdaki</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pepper</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal (18)F-DOPA PET and voxel-based morphometry study</article-title>
                  <source>Mol Psychiatry</source>
                  <year>2021</year>
                  <volume>26</volume>
                  <fpage>1332</fpage>
                  <lpage>45</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41380-019-0570-6</pub-id>
                  <?supplied-pmid 31690805?>
                  <pub-id pub-id-type="pmid">31690805</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Casey</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Cherkasova</surname>
                      <given-names>MV</given-names>
                    </name>
                    <name>
                      <surname>Larcher</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>GB</given-names>
                    </name>
                    <name>
                      <surname>Dagher</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans</article-title>
                  <source>J Neurosci</source>
                  <year>2013</year>
                  <volume>33</volume>
                  <fpage>15285</fpage>
                  <lpage>94</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5029-12.2013</pub-id>
                  <?supplied-pmid 24048857?>
                  <pub-id pub-id-type="pmid">24048857</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kurose</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kubota</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Takahata</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Yamamoto</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Fujiwara</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Kimura</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Relationship between regional gray matter volumes and dopamine D2 receptor and transporter in living human brains</article-title>
                  <source>Hum Brain Mapp</source>
                  <year>2021</year>
                  <volume>42</volume>
                  <fpage>4048</fpage>
                  <lpage>58</lpage>
                  <pub-id pub-id-type="doi">10.1002/hbm.25538</pub-id>
                  <?supplied-pmid 34014611?>
                  <pub-id pub-id-type="pmid">34014611</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCutcheon</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Abi-Dargham</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Howes</surname>
                      <given-names>OD</given-names>
                    </name>
                  </person-group>
                  <article-title>Schizophrenia, dopamine and the striatum: from biology to symptoms</article-title>
                  <source>Trends Neurosci</source>
                  <year>2019</year>
                  <volume>42</volume>
                  <fpage>205</fpage>
                  <lpage>20</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tins.2018.12.004</pub-id>
                  <?supplied-pmid 30621912?>
                  <pub-id pub-id-type="pmid">30621912</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gleich</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Deserno</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lorenz</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Boehme</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Pankow</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Buchert</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prefrontal and striatal glutamate differently relate to striatal dopamine: potential regulatory mechanisms of striatal presynaptic dopamine function?</article-title>
                  <source>J Neurosci</source>
                  <year>2015</year>
                  <volume>35</volume>
                  <fpage>9615</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0329-15.2015</pub-id>
                  <?supplied-pmid 26134644?>
                  <pub-id pub-id-type="pmid">26134644</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harada</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pascoli</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Hiver</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Flakowski</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Luscher</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Corticostriatal activity driving compulsive reward seeking</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2021</year>
                  <volume>90</volume>
                  <fpage>808</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biopsych.2021.08.018</pub-id>
                  <?supplied-pmid 34688471?>
                  <pub-id pub-id-type="pmid">34688471</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Minkowicz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dumrongprechachan</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kozorovitskiy</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Ketamine rapidly enhances glutamate-evoked dendritic spinogenesis in medial prefrontal cortex through dopaminergic mechanisms</article-title>
                  <source>Biol Psychiatry</source>
                  <year>2021</year>
                  <volume>89</volume>
                  <fpage>1096</fpage>
                  <lpage>105</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biopsych.2020.12.022</pub-id>
                  <?supplied-pmid 33637303?>
                  <pub-id pub-id-type="pmid">33637303</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>IH</given-names>
                    </name>
                    <name>
                      <surname>Rossi</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Aryal</surname>
                      <given-names>DK</given-names>
                    </name>
                    <name>
                      <surname>Racz</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Uezu</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine</article-title>
                  <source>Nat Neurosci</source>
                  <year>2015</year>
                  <volume>18</volume>
                  <fpage>883</fpage>
                  <lpage>91</lpage>
                  <pub-id pub-id-type="doi">10.1038/nn.4015</pub-id>
                  <?supplied-pmid 25938885?>
                  <pub-id pub-id-type="pmid">25938885</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Debbane</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Salaminios</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Luyten</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Badoud</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Armando</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Solida Tozzi</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Attachment, neurobiology, and mentalizing along the psychosis continuum</article-title>
                  <source>Front Hum Neurosci</source>
                  <year>2016</year>
                  <volume>10</volume>
                  <fpage>406</fpage>
                  <pub-id pub-id-type="doi">10.3389/fnhum.2016.00406</pub-id>
                  <?supplied-pmid 27597820?>
                  <pub-id pub-id-type="pmid">27597820</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Egerton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hirani</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ahmad</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Turton</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Brickute</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Rosso</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding</article-title>
                  <source>Synapse</source>
                  <year>2010</year>
                  <volume>64</volume>
                  <fpage>301</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1002/syn.20718</pub-id>
                  <?supplied-pmid 19957364?>
                  <pub-id pub-id-type="pmid">19957364</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shotbolt</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Tziortzi</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Searle</surname>
                      <given-names>GE</given-names>
                    </name>
                    <name>
                      <surname>Colasanti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>van der Aart</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Abanades</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <year>2012</year>
                  <volume>32</volume>
                  <fpage>127</fpage>
                  <lpage>36</lpage>
                  <pub-id pub-id-type="doi">10.1038/jcbfm.2011.115</pub-id>
                  <?supplied-pmid 21878947?>
                  <pub-id pub-id-type="pmid">21878947</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCutcheon</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Krystal</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Howes</surname>
                      <given-names>OD</given-names>
                    </name>
                  </person-group>
                  <article-title>Dopamine and glutamate in schizophrenia: biology, symptoms and treatment</article-title>
                  <source>World Psychiatry</source>
                  <year>2020</year>
                  <volume>19</volume>
                  <fpage>15</fpage>
                  <lpage>33</lpage>
                  <pub-id pub-id-type="doi">10.1002/wps.20693</pub-id>
                  <?supplied-pmid 31922684?>
                  <pub-id pub-id-type="pmid">31922684</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Caravaggio</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Porco</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Torres-Carmona</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Iwata</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Measuring amphetamine-induced dopamine release in humans: A comparative meta-analysis of [(11) C]-raclopride and [(11) C]-(+)-PHNO studies</article-title>
                  <source>Synapse</source>
                  <year>2021</year>
                  <volume>75</volume>
                  <fpage>e22195</fpage>
                  <pub-id pub-id-type="doi">10.1002/syn.22195</pub-id>
                  <?supplied-pmid 33471400?>
                  <pub-id pub-id-type="pmid">33471400</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <mixed-citation publication-type="other">Ashburner J, Friston KJ. Voxel Based Morphometry. In: Squire LR (ed). Encyclopedia of Neuroscience. Academic Press: Oxford, 2009, pp 471–7.</mixed-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Catana</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Principles of simultaneous PET/MR imaging</article-title>
                  <source>Magn Reson Imaging Clin N. Am</source>
                  <year>2017</year>
                  <volume>25</volume>
                  <fpage>231</fpage>
                  <lpage>43</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mric.2017.01.002</pub-id>
                  <?supplied-pmid 28390525?>
                  <pub-id pub-id-type="pmid">28390525</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tahmasian</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Eggers</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Riedl</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Sorg</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Drzezga</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Editorial: utilization of hybrid PET/MR in neuroimaging</article-title>
                  <source>Basic Clin Neurosci</source>
                  <year>2015</year>
                  <volume>6</volume>
                  <fpage>143</fpage>
                  <lpage>5</lpage>
                  <?supplied-pmid 26904170?>
                  <pub-id pub-id-type="pmid">26904170</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCutcheon</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Nour</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Veronese</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zelaya</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illness</article-title>
                  <source>Sci Adv</source>
                  <year>2021</year>
                  <volume>7</volume>
                  <fpage>eabg1512</fpage>
                  <pub-id pub-id-type="doi">10.1126/sciadv.abg1512</pub-id>
                  <?supplied-pmid 34108214?>
                  <pub-id pub-id-type="pmid">34108214</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Asghar</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Tanay</surname>
                      <given-names>VA</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>GB</given-names>
                    </name>
                    <name>
                      <surname>Greenshaw</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Silverstone</surname>
                      <given-names>PH</given-names>
                    </name>
                  </person-group>
                  <article-title>Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers</article-title>
                  <source>Hum Psychopharmacol</source>
                  <year>2003</year>
                  <volume>18</volume>
                  <fpage>291</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1002/hup.480</pub-id>
                  <?supplied-pmid 12766934?>
                  <pub-id pub-id-type="pmid">12766934</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Galineau</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Garcia</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Houle</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kapur</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ginovart</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system</article-title>
                  <source>Synapse</source>
                  <year>2006</year>
                  <volume>60</volume>
                  <fpage>172</fpage>
                  <lpage>83</lpage>
                  <pub-id pub-id-type="doi">10.1002/syn.20290</pub-id>
                  <?supplied-pmid 16715499?>
                  <pub-id pub-id-type="pmid">16715499</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Gallezot</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>MQ</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>YS</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Test-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm</article-title>
                  <source>Mol Imaging</source>
                  <year>2013</year>
                  <volume>12</volume>
                  <fpage>77</fpage>
                  <lpage>82</lpage>
                  <?supplied-pmid 23415395?>
                  <pub-id pub-id-type="pmid">23415395</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gallezot</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>MQ</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Labaree</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Matuskey</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Parametric Imaging and Test-Retest Variability of (1)(1)C-(+)-PHNO Binding to D(2)/D(3) Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner</article-title>
                  <source>J Nucl Med</source>
                  <year>2014</year>
                  <volume>55</volume>
                  <fpage>960</fpage>
                  <lpage>6</lpage>
                  <pub-id pub-id-type="doi">10.2967/jnumed.113.132928</pub-id>
                  <?supplied-pmid 24732151?>
                  <pub-id pub-id-type="pmid">24732151</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vandenberghe</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Marsden</surname>
                      <given-names>PK</given-names>
                    </name>
                  </person-group>
                  <article-title>PET-MRI: a review of challenges and solutions in the development of integrated multimodality imaging</article-title>
                  <source>Phys Med Biol</source>
                  <year>2015</year>
                  <volume>60</volume>
                  <fpage>R115</fpage>
                  <lpage>154</lpage>
                  <pub-id pub-id-type="doi">10.1088/0031-9155/60/4/R115</pub-id>
                  <?supplied-pmid 25650582?>
                  <pub-id pub-id-type="pmid">25650582</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chicheportiche</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Marciano</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Orevi</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of NEMA characterizations for Discovery MI and Discovery MI-DR TOF PET/CT systems at different sites and with other commercial PET/CT systems</article-title>
                  <source>EJNMMI Phys</source>
                  <year>2020</year>
                  <volume>7</volume>
                  <fpage>4</fpage>
                  <pub-id pub-id-type="doi">10.1186/s40658-020-0271-x</pub-id>
                  <?supplied-pmid 31938953?>
                  <pub-id pub-id-type="pmid">31938953</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hudson</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Larkin</surname>
                      <given-names>RS</given-names>
                    </name>
                  </person-group>
                  <article-title>Accelerated image reconstruction using ordered subsets of projection data</article-title>
                  <source>IEEE Trans Med Imaging</source>
                  <year>1994</year>
                  <volume>13</volume>
                  <fpage>601</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1109/42.363108</pub-id>
                  <?supplied-pmid 18218538?>
                  <pub-id pub-id-type="pmid">18218538</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sousa</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Appel</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Engstrom</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Papadimitriou</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Nyholm</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Larsson</surname>
                      <given-names>EM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and (68)Ge-transmission-based attenuation correction</article-title>
                  <source>EJNMMI Phys</source>
                  <year>2018</year>
                  <volume>5</volume>
                  <fpage>20</fpage>
                  <pub-id pub-id-type="doi">10.1186/s40658-018-0220-0</pub-id>
                  <?supplied-pmid 30345471?>
                  <pub-id pub-id-type="pmid">30345471</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jauhar</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>McCutcheon</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Borgan</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Veronese</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Nour</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pepper</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study</article-title>
                  <source>Lancet Psychiatry</source>
                  <year>2018</year>
                  <volume>5</volume>
                  <fpage>816</fpage>
                  <lpage>23</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2215-0366(18)30268-2</pub-id>
                  <?supplied-pmid 30236864?>
                  <pub-id pub-id-type="pmid">30236864</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gunn</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Coello</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Searle</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Molecular imaging and kinetic analysis toolbox (MIAKAT) - a quantitative software package for the analysis of PET neuroimaging data</article-title>
                  <source>J Nucl Med</source>
                  <year>2016</year>
                  <volume>57</volume>
                  <fpage>1928</fpage>
                  <lpage>1928</lpage>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jiao</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Searle</surname>
                      <given-names>GE</given-names>
                    </name>
                    <name>
                      <surname>Schnabel</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Gunn</surname>
                      <given-names>RN</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of image-based motion correction on dopamine D3/D2 receptor occupancy-comparison of groupwise and frame-by-frame registration approaches</article-title>
                  <source>EJNMMI Phys</source>
                  <year>2015</year>
                  <volume>2</volume>
                  <fpage>15</fpage>
                  <pub-id pub-id-type="doi">10.1186/s40658-015-0117-0</pub-id>
                  <?supplied-pmid 26501816?>
                  <pub-id pub-id-type="pmid">26501816</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martinez</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Broft</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mawlawi</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Hwang</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <year>2003</year>
                  <volume>23</volume>
                  <fpage>285</fpage>
                  <lpage>300</lpage>
                  <pub-id pub-id-type="doi">10.1097/01.WCB.0000048520.34839.1A</pub-id>
                  <?supplied-pmid 12621304?>
                  <pub-id pub-id-type="pmid">12621304</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gunn</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>Lammertsma</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Hume</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>Cunningham</surname>
                      <given-names>VJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Parametric imaging of ligand-receptor binding in PET using a simplified reference region model</article-title>
                  <source>Neuroimage</source>
                  <year>1997</year>
                  <volume>6</volume>
                  <fpage>279</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.1006/nimg.1997.0303</pub-id>
                  <?supplied-pmid 9417971?>
                  <pub-id pub-id-type="pmid">9417971</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lammertsma</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Hume</surname>
                      <given-names>SP</given-names>
                    </name>
                  </person-group>
                  <article-title>Simplified reference tissue model for PET receptor studies</article-title>
                  <source>Neuroimage</source>
                  <year>1996</year>
                  <volume>4</volume>
                  <fpage>153</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1006/nimg.1996.0066</pub-id>
                  <?supplied-pmid 9345505?>
                  <pub-id pub-id-type="pmid">9345505</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levant</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Grigoriadis</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>DeSouza</surname>
                      <given-names>EB</given-names>
                    </name>
                  </person-group>
                  <article-title>[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study</article-title>
                  <source>J Pharm Exp Ther</source>
                  <year>1993</year>
                  <volume>264</volume>
                  <fpage>991</fpage>
                  <lpage>1001</lpage>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ashburner</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>A fast diffeomorphic image registration algorithm</article-title>
                  <source>Neuroimage</source>
                  <year>2007</year>
                  <volume>38</volume>
                  <fpage>95</fpage>
                  <lpage>113</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.07.007</pub-id>
                  <?supplied-pmid 17761438?>
                  <pub-id pub-id-type="pmid">17761438</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Malone</surname>
                      <given-names>IB</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>KK</given-names>
                    </name>
                    <name>
                      <surname>Clegg</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Whitwell</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Ashburner</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance</article-title>
                  <source>Neuroimage</source>
                  <year>2015</year>
                  <volume>104</volume>
                  <fpage>366</fpage>
                  <lpage>72</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.09.034</pub-id>
                  <?supplied-pmid 25255942?>
                  <pub-id pub-id-type="pmid">25255942</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maldjian</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Laurienti</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Kraft</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Burdette</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <article-title>An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets</article-title>
                  <source>Neuroimage</source>
                  <year>2003</year>
                  <volume>19</volume>
                  <fpage>1233</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1053-8119(03)00169-1</pub-id>
                  <?supplied-pmid 12880848?>
                  <pub-id pub-id-type="pmid">12880848</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maldjian</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Laurienti</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Burdette</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <article-title>Precentral gyrus discrepancy in electronic versions of the Talairach atlas</article-title>
                  <source>Neuroimage</source>
                  <year>2004</year>
                  <volume>21</volume>
                  <fpage>450</fpage>
                  <lpage>5</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2003.09.032</pub-id>
                  <?supplied-pmid 14741682?>
                  <pub-id pub-id-type="pmid">14741682</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haber</surname>
                      <given-names>SN</given-names>
                    </name>
                  </person-group>
                  <article-title>Corticostriatal circuitry</article-title>
                  <source>Dialogues Clin Neurosci</source>
                  <year>2016</year>
                  <volume>18</volume>
                  <fpage>7</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.31887/DCNS.2016.18.1/shaber</pub-id>
                  <?supplied-pmid 27069376?>
                  <pub-id pub-id-type="pmid">27069376</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Howes</surname>
                      <given-names>OD</given-names>
                    </name>
                    <name>
                      <surname>Allen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Broome</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Valli</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Asselin</surname>
                      <given-names>MC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis</article-title>
                  <source>Mol Psychiatry</source>
                  <year>2011</year>
                  <volume>16</volume>
                  <fpage>67</fpage>
                  <lpage>75</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2009.108</pub-id>
                  <?supplied-pmid 19949389?>
                  <pub-id pub-id-type="pmid">19949389</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rorden</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Brett</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Stereotaxic display of brain lesions</article-title>
                  <source>Behav Neurol</source>
                  <year>2000</year>
                  <volume>12</volume>
                  <fpage>191</fpage>
                  <lpage>200</lpage>
                  <pub-id pub-id-type="doi">10.1155/2000/421719</pub-id>
                  <?supplied-pmid 11568431?>
                  <pub-id pub-id-type="pmid">11568431</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Willeit</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ginovart</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Graff</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Rusjan</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Vitcu</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Houle</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study</article-title>
                  <source>Neuropsychopharmacology</source>
                  <year>2008</year>
                  <volume>33</volume>
                  <fpage>279</fpage>
                  <lpage>89</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.npp.1301400</pub-id>
                  <?supplied-pmid 17406650?>
                  <pub-id pub-id-type="pmid">17406650</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Graff-Guerrero</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Willeit</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ginovart</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Mamo</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Mizrahi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rusjan</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans</article-title>
                  <source>Hum Brain Mapp</source>
                  <year>2008</year>
                  <volume>29</volume>
                  <fpage>400</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1002/hbm.20392</pub-id>
                  <?supplied-pmid 17497628?>
                  <pub-id pub-id-type="pmid">17497628</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Howes</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>McCutcheon</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Glutamate and dopamine in schizophrenia: an update for the 21st century</article-title>
                  <source>J Psychopharmacol</source>
                  <year>2015</year>
                  <volume>29</volume>
                  <fpage>97</fpage>
                  <lpage>115</lpage>
                  <pub-id pub-id-type="doi">10.1177/0269881114563634</pub-id>
                  <?supplied-pmid 25586400?>
                  <pub-id pub-id-type="pmid">25586400</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Howes</surname>
                      <given-names>OD</given-names>
                    </name>
                    <name>
                      <surname>Kapur</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)</article-title>
                  <source>Br J Psychiatry</source>
                  <year>2014</year>
                  <volume>205</volume>
                  <fpage>1</fpage>
                  <lpage>3</lpage>
                  <pub-id pub-id-type="doi">10.1192/bjp.bp.113.138578</pub-id>
                  <?supplied-pmid 24986384?>
                  <pub-id pub-id-type="pmid">24986384</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Egerton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Donocik</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Anton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Barker</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Collier</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance spectroscopy study (STRATA)</article-title>
                  <source>Schizophr Bull</source>
                  <year>2021</year>
                  <volume>47</volume>
                  <fpage>505</fpage>
                  <lpage>16</lpage>
                  <pub-id pub-id-type="doi">10.1093/schbul/sbaa128</pub-id>
                  <?supplied-pmid 32910150?>
                  <pub-id pub-id-type="pmid">32910150</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beckmann</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Johansen-Berg</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Rushworth</surname>
                      <given-names>MF</given-names>
                    </name>
                  </person-group>
                  <article-title>Connectivity-based parcellation of human cingulate cortex and its relation to functional specialization</article-title>
                  <source>J Neurosci</source>
                  <year>2009</year>
                  <volume>29</volume>
                  <fpage>1175</fpage>
                  <lpage>90</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3328-08.2009</pub-id>
                  <?supplied-pmid 19176826?>
                  <pub-id pub-id-type="pmid">19176826</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cachope</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cheer</surname>
                      <given-names>JF</given-names>
                    </name>
                  </person-group>
                  <article-title>Local control of striatal dopamine release</article-title>
                  <source>Front Behav Neurosci</source>
                  <year>2014</year>
                  <volume>8</volume>
                  <fpage>188</fpage>
                  <pub-id pub-id-type="doi">10.3389/fnbeh.2014.00188</pub-id>
                  <?supplied-pmid 24904339?>
                  <pub-id pub-id-type="pmid">24904339</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Howes</surname>
                      <given-names>OD</given-names>
                    </name>
                    <name>
                      <surname>Kambeitz</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Stahl</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Abi-Dargham</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The nature of dopamine dysfunction in schizophrenia and what this means for treatment</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <year>2012</year>
                  <volume>69</volume>
                  <fpage>776</fpage>
                  <lpage>86</lpage>
                  <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2012.169</pub-id>
                  <?supplied-pmid 22474070?>
                  <pub-id pub-id-type="pmid">22474070</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brannan</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Sawchak</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Lieberman</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Paul</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Breier</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia</article-title>
                  <source>N. Engl J Med</source>
                  <year>2021</year>
                  <volume>384</volume>
                  <fpage>717</fpage>
                  <lpage>26</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2017015</pub-id>
                  <?supplied-pmid 33626254?>
                  <pub-id pub-id-type="pmid">33626254</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koblan</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Kent</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hopkins</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Krystal</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Goldman</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A non-D2-receptor-binding drug for the treatment of schizophrenia</article-title>
                  <source>N. Engl J Med</source>
                  <year>2020</year>
                  <volume>382</volume>
                  <fpage>1497</fpage>
                  <lpage>506</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1911772</pub-id>
                  <?supplied-pmid 32294346?>
                  <pub-id pub-id-type="pmid">32294346</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jaworska</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Casey</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Boileau</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Cherkasova</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Larcher</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness?</article-title>
                  <source>PLoS One</source>
                  <year>2017</year>
                  <volume>12</volume>
                  <fpage>e0174219</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0174219</pub-id>
                  <?supplied-pmid 28346539?>
                  <pub-id pub-id-type="pmid">28346539</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Caravaggio</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ku Chung</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Plitman</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Boileau</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Gerretsen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET</article-title>
                  <source>Hum Brain Mapp</source>
                  <year>2017</year>
                  <volume>38</volume>
                  <fpage>5519</fpage>
                  <lpage>34</lpage>
                  <pub-id pub-id-type="doi">10.1002/hbm.23744</pub-id>
                  <?supplied-pmid 28752565?>
                  <pub-id pub-id-type="pmid">28752565</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <mixed-citation publication-type="other">Sharbaf Shoar N, Marwaha R, Molla M. Dextroamphetamine-amphetamine. StatPearls: Treasure Island (FL), 2021.</mixed-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Poels</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Kegeles</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Kantrowitz</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Javitt</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Lieberman</surname>
                      <given-names>JA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Imaging glutamate in schizophrenia: review of findings and implications for drug discovery</article-title>
                  <source>Mol Psychiatry</source>
                  <year>2014</year>
                  <volume>19</volume>
                  <fpage>20</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2013.136</pub-id>
                  <?supplied-pmid 24166406?>
                  <pub-id pub-id-type="pmid">24166406</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
